Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway.
Stem Cell Res Ther
; 13(1): 305, 2022 07 15.
Article
in En
| MEDLINE
| ID: mdl-35841070
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Periodontal Ligament
/
Receptors, Atrial Natriuretic Factor
/
MAP Kinase Signaling System
/
Metformin
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Stem Cell Res Ther
Year:
2022
Type:
Article